Literature DB >> 11135485

Reconstruction of the perineum.

J Friedman1, T Dinh, J Potochny.   

Abstract

Defects of the perineal area commonly occur following ablative procedures for gynecological, urological, and colorectal malignancies. A coordinated approach between the surgical oncologist and the reconstructive surgeon is necessary in order to achieve appropriate results in these patients. Consideration of both form and function is essential and must be planned for. A variety of reconstructive procedures, including skin grafts, local skin flaps, various myocutaneous and fasciocutaneous flaps and, in rare situations, free tissue transfers, are used in the closure of these wounds. An algorithm for the selection of these various procedures is presented so that uncomplicated wound healing can be achieved and functional results can be optimized. Semin. Surg. Oncol. 19:282-293, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11135485     DOI: 10.1002/1098-2388(200010/11)19:3<282::aid-ssu10>3.0.co;2-b

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  4 in total

1.  [Persistent perineal sinus closure after rectal extirpation-an alternative using bulbocavernosus fat flaps].

Authors:  M Kaminski; M Sippel; A Hirner
Journal:  Chirurg       Date:  2004-06       Impact factor: 0.955

2.  Reconstruction of acquired defects of the vagina and perineum.

Authors:  Christopher J Salgado; Harvey Chim; Piotr P Skowronski; John Oeltjen; Meily Rodriguez; Samir Mardini
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

3.  Reconstruction of acquired perineovulvar defects: a proposal of sequence.

Authors:  J Joris Hage; Marc van Beurden
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

4.  Surgical therapy of vulvar cancer: how to choose the correct reconstruction?

Authors:  Stefano Gentileschi; Maria Servillo; Giorgia Garganese; Simona Fragomeni; Francesca De Bonis; Giovanni Scambia; Marzia Salgarello
Journal:  J Gynecol Oncol       Date:  2016-07-12       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.